Cargando…

Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals

BACKGROUND: Therapeutic inertia, defined as failure to escalate or initiate adequate therapy when treatment goals are not met, contributes to poor management of COPD exacerbations. METHODS: A multidisciplinary panel of five expert clinicians actively managing COPD and representative of UK practice d...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Holmes, Steve, Adams, Claire, Bafadhel, Mona, Hurst, John R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570921/
https://www.ncbi.nlm.nih.gov/pubmed/34754186
http://dx.doi.org/10.2147/COPD.S329316
_version_ 1784594919930724352
author Singh, Dave
Holmes, Steve
Adams, Claire
Bafadhel, Mona
Hurst, John R
author_facet Singh, Dave
Holmes, Steve
Adams, Claire
Bafadhel, Mona
Hurst, John R
author_sort Singh, Dave
collection PubMed
description BACKGROUND: Therapeutic inertia, defined as failure to escalate or initiate adequate therapy when treatment goals are not met, contributes to poor management of COPD exacerbations. METHODS: A multidisciplinary panel of five expert clinicians actively managing COPD and representative of UK practice developed action points to reduce exacerbation risk, based on evidence, clinical expertise, and experience. The action points are applicable despite changing circumstances (eg, virtual clinics). The panel agreed areas where further evidence is needed. RESULTS: The four action points were (1) an experienced HCP, such as a GP or member of the multi-professional COPD team should review patients within one month of every exacerbation that requires oral steroids, antibiotics, or hospitalization to address modifiable risk factors, optimize non-pharmacological measures, and evaluate pharmacological therapy. (2) Presenting to hospital with an exacerbation defines an important window of opportunity to reduce the risk of further exacerbations. Follow-up by a GP, or member of the multi-professional specialist COPD team within one month of discharge with a full management review and appropriate escalation of pharmacological treatment is essential. (3) Healthcare professionals (HCPs) in all healthcare settings should be able to recognize COPD exacerbations, refer as appropriate and document the episode accurately in medical records across service boundaries. HCPs should support patients to recognize and report exacerbations. (4) HCPs should intervene proactively based on risk assessments, disease activity and any treatable traits at or as soon as possible after diagnosis and annually thereafter. Delivering these action points needs coordinated action with policymakers, funders, and service providers. CONCLUSION: These action points should be a fundamental part of clinical practice to determine if a change in management is necessary to reduce the risk of exacerbations. Policymakers should use these action points to develop systems and initiatives that reduce the risk of further exacerbations.
format Online
Article
Text
id pubmed-8570921
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85709212021-11-08 Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals Singh, Dave Holmes, Steve Adams, Claire Bafadhel, Mona Hurst, John R Int J Chron Obstruct Pulmon Dis Expert Opinion BACKGROUND: Therapeutic inertia, defined as failure to escalate or initiate adequate therapy when treatment goals are not met, contributes to poor management of COPD exacerbations. METHODS: A multidisciplinary panel of five expert clinicians actively managing COPD and representative of UK practice developed action points to reduce exacerbation risk, based on evidence, clinical expertise, and experience. The action points are applicable despite changing circumstances (eg, virtual clinics). The panel agreed areas where further evidence is needed. RESULTS: The four action points were (1) an experienced HCP, such as a GP or member of the multi-professional COPD team should review patients within one month of every exacerbation that requires oral steroids, antibiotics, or hospitalization to address modifiable risk factors, optimize non-pharmacological measures, and evaluate pharmacological therapy. (2) Presenting to hospital with an exacerbation defines an important window of opportunity to reduce the risk of further exacerbations. Follow-up by a GP, or member of the multi-professional specialist COPD team within one month of discharge with a full management review and appropriate escalation of pharmacological treatment is essential. (3) Healthcare professionals (HCPs) in all healthcare settings should be able to recognize COPD exacerbations, refer as appropriate and document the episode accurately in medical records across service boundaries. HCPs should support patients to recognize and report exacerbations. (4) HCPs should intervene proactively based on risk assessments, disease activity and any treatable traits at or as soon as possible after diagnosis and annually thereafter. Delivering these action points needs coordinated action with policymakers, funders, and service providers. CONCLUSION: These action points should be a fundamental part of clinical practice to determine if a change in management is necessary to reduce the risk of exacerbations. Policymakers should use these action points to develop systems and initiatives that reduce the risk of further exacerbations. Dove 2021-11-01 /pmc/articles/PMC8570921/ /pubmed/34754186 http://dx.doi.org/10.2147/COPD.S329316 Text en © 2021 Singh et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Expert Opinion
Singh, Dave
Holmes, Steve
Adams, Claire
Bafadhel, Mona
Hurst, John R
Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
title Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
title_full Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
title_fullStr Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
title_full_unstemmed Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
title_short Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
title_sort overcoming therapeutic inertia to reduce the risk of copd exacerbations: four action points for healthcare professionals
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570921/
https://www.ncbi.nlm.nih.gov/pubmed/34754186
http://dx.doi.org/10.2147/COPD.S329316
work_keys_str_mv AT singhdave overcomingtherapeuticinertiatoreducetheriskofcopdexacerbationsfouractionpointsforhealthcareprofessionals
AT holmessteve overcomingtherapeuticinertiatoreducetheriskofcopdexacerbationsfouractionpointsforhealthcareprofessionals
AT adamsclaire overcomingtherapeuticinertiatoreducetheriskofcopdexacerbationsfouractionpointsforhealthcareprofessionals
AT bafadhelmona overcomingtherapeuticinertiatoreducetheriskofcopdexacerbationsfouractionpointsforhealthcareprofessionals
AT hurstjohnr overcomingtherapeuticinertiatoreducetheriskofcopdexacerbationsfouractionpointsforhealthcareprofessionals